Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 55Neoplasm Metastasis 3Stage II Prostate Adenocarcinoma 1Sleep Initiation and Maintenance Disorders 1Salivary Gland Neoplasms 1Prostate Cancer Metastatic Disease 1Prostate Cancer Metastatic 1Newly Diagnosed Oligometastatic Prostate Cancer 1Metastatic Hormone-sensitive Prostate Cancer 1Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1Metastatic Castration-resistant Prostate Neoplasms 1Metastatic Castration-Resistant Prostate Cancer 1Metastatic Castrate-sensitive Prostate Cancer 1Low Risk Prostate Cancer 1Fatigue 1Depression 1Castration Levels of Testosterone 1Adenocarcinoma 1

Interventions

apalutamide 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metastatic Castrate-sensitive Prostate Cancer × apalutamide × 1 year × Clear all
NCT05884398 2026-06-05

LIBERTAS

Janssen Research & Development, LLC

Phase 3 Active not recruiting
420 enrolled
Genitourinary

Metastatic Castrate-sensitive Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡